Trials / Unknown
UnknownNCT05956769
Goal-directed vs Preemptive Tranexamic Acid Administration in Total Hip Arthroplasty
Comparison of TEG-guided and Preemptive Tranexamic Acid Administration Strategies in Total Hip Replacement Surgery
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 84 (estimated)
- Sponsor
- Konkuk University Medical Center · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The present study is a multi-center randomized prospective placebo-controlled non-inferiority trial. The study's primary objective is to compare the amounts of postoperative bleeding using two different TXA administration strategies: empirical TXA administration vs. viscoelastic test-based Goal-directed vs Preemptive Tranexamic Acid Administration in total hip arthroplasty. The secondary objectives include comparing the incidents of hyper-fibrinolysis, thromboembolic complications, and postoperative seizures. Researchers assumed that goal-directed tranexamic acid (TXA) administration using viscoelastic field tests would not be inferior to the empirical TXA administration strategy in reducing postoperative bleeding and hyper-fibrinolysis. It also would be beneficial in lowering TXA-induced thromboembolic complications and seizures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tranexamic Acid | Tranexamic acid injection 10 mg/kg and infusion 2 mg/kg/hr |
| DIAGNOSTIC_TEST | thromboelastography | thromboelastography (TEG6) |
| DRUG | Placebo | Normal saline injection |
Timeline
- Start date
- 2024-02-01
- Primary completion
- 2024-11-30
- Completion
- 2024-12-31
- First posted
- 2023-07-21
- Last updated
- 2024-01-02
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05956769. Inclusion in this directory is not an endorsement.